Get Breaking Business News headlines emailed to you daily.
Novartis' Diovan Modestly Reduced Diabetes Risk In Study Source: Fox Business Sunday 14th March, 2010
A new study found that Novartis AG's (NVS, NOVN.VX) blockbuster blood-pressure drug Diovan modestly lowered the incidence of diabetes in certain high-risk patients, but another Novartis drug failed t... ...
